Correlation Between Avenue Therapeutics and ESSA Pharma
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and ESSA Pharma, you can compare the effects of market volatilities on Avenue Therapeutics and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and ESSA Pharma.
Diversification Opportunities for Avenue Therapeutics and ESSA Pharma
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Avenue and ESSA is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and ESSA Pharma go up and down completely randomly.
Pair Corralation between Avenue Therapeutics and ESSA Pharma
Given the investment horizon of 90 days Avenue Therapeutics is expected to generate 0.19 times more return on investment than ESSA Pharma. However, Avenue Therapeutics is 5.27 times less risky than ESSA Pharma. It trades about -0.32 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.14 per unit of risk. If you would invest 252.00 in Avenue Therapeutics on August 27, 2024 and sell it today you would lose (51.00) from holding Avenue Therapeutics or give up 20.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avenue Therapeutics vs. ESSA Pharma
Performance |
| Timeline |
| Avenue Therapeutics |
| ESSA Pharma |
Avenue Therapeutics and ESSA Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avenue Therapeutics and ESSA Pharma
The main advantage of trading using opposite Avenue Therapeutics and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.| Avenue Therapeutics vs. Capricor Therapeutics | Avenue Therapeutics vs. Soleno Therapeutics | Avenue Therapeutics vs. Bio Path Holdings | Avenue Therapeutics vs. Moleculin Biotech |
| ESSA Pharma vs. Altamira Therapeutics | ESSA Pharma vs. Summit Therapeutics PLC | ESSA Pharma vs. Avenue Therapeutics | ESSA Pharma vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |